NCT00674102 2020-12-09
An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC)
Novartis
Phase 1 Completed
Clinical Trials
7 trialsNCT01285453 2020-12-09
Safety and Tolerability of ASA404 Administered in Combination With Docetaxel in Japanese Patients With Solid Tumors
Novartis
Phase 1 Completed
NCT00003697 2013-12-19
Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT01057342 2013-04-10
Paclitaxel, Carboplatin, and Dimethylxanthenone Acetic Acid in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Swiss Cancer Institute
Phase 2 Completed
NCT00863733 2009-03-18
DMXAA
Cancer Research UK
Phase 1 Completed
NCT00856336 2009-03-05
DART
Antisoma Research
Phase 1 Completed
NCT00111618 2009-01-30
Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
Antisoma Research
Phase 2 Completed